GO
Loading...

Enter multiple symbols separated by commas

Search results for "WPI"

REFINE RESULTS

SEARCH RESULTS

About 9 results. Sort By: Date | Relevance
UPDATE 1-Greenlight's Einhorn slams oil frackers at Sohn conference

NEW YORK, May 4- Billionaire hedge fund manager David Einhorn, who often moves a stock simply by speaking its name, on Monday kicked off the year's most prominent investment conference by laying out a case against oil frackers, arguing these companies drill "lots and lots of holes" and burn through plenty of cash. Einhorn, who often unveils so-called short-bets...
Source: Reuters | By: Svea Herbst-Bayliss, Jessica Toonkel and Ashley Lau
Valeant raises outlook after completing purchase of Salix

LAVAL, Quebec- Valeant Pharmaceuticals International Inc. said Wednesday it turned a profit in the first quarter, and the Canadian drugmaker raised its forecasts for the year after completing more acquisitions. The company reported a profit of $73.7 million, or 21 cents per share, after it lost $22.6 million, or 7 cents per share, a year ago. The Laval, Quebec- based...
Source: The Associated Press
DEALTALK-Drug overlaps, shortages may complicate Teva bid for Mylan

NEW YORK, April 24- Teva Pharmaceutical Industries' bid for Mylan NV would create a company controlling nearly 25 percent of the U.S. generics market, including drugs in short supply, according to industry experts and a Reuters review of regulatory filings. It is also pursuing a hostile takeover of drugmaker Perrigo Co Plc. Teva has already looked at the...
Source: Reuters | By: Caroline Humer and Ransdell Pierson
UPDATE 1-Teva ready to divest operations to win regulatory nod for Mylan buy

April 22- Generic drugmaker Teva Pharmaceutical Industries Ltd said it could "promptly" divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller rival Mylan NV. Mylan, which has said a merger with Teva would be bad fit, plans to make a new offer for Perrigo Co Plc in the near term, CNBC reported on Wednesday.
Source: Reuters
Teva ready to divest operations to win regulatory nod for Mylan buy

April 22- Teva Pharmaceutical Industries Ltd said on Wednesday it could "promptly" divest some operations if necessary to obtain regulatory clearance for its proposed takeover of smaller rival Mylan NV. Meanwhile, Canonsburg, Pennsylvania- based Mylan is pursuing its own $29 billion unsolicited bid for Perrigo Co Plc, which the maker of over-the-counter...
Source: Reuters
UPDATE 1-Top Mylan shareholders seek deal with Teva -sources

April 21- Some of the top investors at Mylan NV, including Paulson& Co, are encouraging its board of directors to consider a takeover proposal from rival Teva Pharmaceutical Industries Inc, according to people familiar with the matter. Teva unveiled an unsolicited $40 billion takeover proposal on Tuesday for the Canonsburg, Pennsylvania- based company.
Source: Reuters | By: Olivia Oran and Nadia Damouni
U.S. court weighs whether to let Actavis drop Alzheimer's drug

NEW YORK, April 13- Actavis Plc urged a U.S. appeals court on Monday to allow it to discontinue a top-selling Alzheimer's drug in favor of a pricier extended-release version, a move that New York's attorney general has said would suppress generic competition. New York Attorney General Eric Schneiderman filed an antitrust lawsuit against Dublin- based Actavis...
Source: Reuters | By: Brendan Pierson
UPDATE 1-Zoetis adds second director under deal with Pershing Square

Zoetis agreed with Pershing Square and Sachem Head Group in February to add two independent directors. The agreement prevents Pershing Square from raising its stake in Zoetis to above 12.5 percent and soliciting any takeover offers for the company or its units. Pershing Square was Zoetis's largest shareholder as of Feb. 3 with an 8.35 percent stake, according...
Source: Reuters
Zoetis adds 2nd director to board under deal with Pershing Square

April 13- Animal health products company Zoetis Inc appointed a second director to its board under its agreement with Bill Ackman's hedge fund Pershing Square Capital Management. Zoetis said on Monday that it added Actavis Plc Executive Chairman and former chief executive Paul Bisaro to its board. Zoetis had appointed William Doyle, a Pershing Square...
Source: Reuters